Advertisement Quintiles Transnational to expand Singapore operations - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Quintiles Transnational to expand Singapore operations

Quintiles Transnational, a contract research organization, has announced that it will expand its Singapore operations to meet the surging demand for its business in the Asia-Pacific region.

The new regional headquarters will be double the size of its existing presence in Singapore and will be the home of the region’s largest clinical development organization. Quintiles’s Asia-Pacific growth also has led to expansion of seven local offices in the region and the addition of a new location in Indonesia.

Quintiles has expanded offices recently in Manila, Taipei, Seoul, Kuala Lumpur, Bangkok, Sydney and Hong Kong. The company also has opened an office in Jakarta. The new location has a capacity of about 400.

Quintiles’s central laboratory and its clinical development services offices will move into approximately 80,000 square feet of space in the Cintech IV building now under construction in Singapore’s Science Park One. The move is planned in the third quarter of 2009.

According to Anand Tharmaratnam, head of clinical development, Quintiles Asia Pacific, the expanded facility renews the company’s commitment to the region and to its partnership with the Singapore Economic Development Board.

Mr Tharmaratnam said. “We are projecting continued strong growth in the future, and this new facility gives us the room we will need. The new location also will allow us to work more efficiently, share best practices and deliver truly turnkey solutions to our customers.”